PrEP Shown To Be Highly Efficacious Across All Populations, But Global Coverage Still Far Short Of 2020 Target, UNAIDS Says

UNAIDS: Highly effective HIV prevention option not reaching those who need it
“Pre-exposure prophylaxis (PrEP), an HIV prevention option whereby someone who is HIV-negative takes antiretroviral medicines prior to possible exposure to HIV, has been shown to be highly efficacious across all populations. … The number of people reported to have received PrEP at least once in the previous year has increased dramatically in recent years, from fewer than 2,000 in 2016 to more than 590,000 in 2019. In several cities in North America, Europe, and Australia where PrEP is widely available, this relatively new prevention tool has contributed to steep reductions in HIV infections among gay men and other men who have sex with men. Global coverage, however, is still far short of the 2020 target of 3 million people receiving PrEP” (11/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.